Clinical Trial Update: The Efficacy of Risedronate in Prevention of Bone Loss in Patients Receiving High Dose Corticosteroid Treatment [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated whether risedronate prevents corticosteroid-induced bone loss in osteoporosis patients and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corticosteroid-induced Osteoporosis
• Osteoporosis

Drugs mentioned

• risedronate (risedronate)

Snippet

Sponsor: Tuen Mun Hospital | Conditions: Osteoporosis | Phase 4 | Status: COMPLETED